Annual report 2016 now online In our annual report, we look back at compelling RIVM projects and research in which RIVM was involved in 2016. Our expertise is broader than what we can showcase in this report.
Risks of potential release of genetically modified mosquitoes evaluated On Saba, a Dutch Caribbean island, diseases such as dengue, chikungunya and zika can be reduced by the use of genetically modified mosquitoes.
Resistant bacteria in wastewater Our wastewater contains bacteria that are resistant to antibiotics. Residues of antibiotics are also found in wastewater.
Trend scenario PHF- 2018 identifies societal challenges for the future If historical trends continue unchanged, dementia will be the leading cause of disease burden in 2040 and the main cause of death.
Antimicrobial resistance is stable, but alertness remains necessary The number of bacteria strains resistant to antibiotics in humans has remained stable in the Netherlands over the past year.
Benefits and bottlenecks for early marketing authorisation of new medicines Patients are asking increasingly often for quicker access to new, innovative medicines. This requires a more effective use of flexible marketing authorisation procedures.
European Baseline Report SUSTAIN The SUSTAIN project has published the European baseline report titled ‘Integrated care for older people living at home – Current situation and ambition of sites participating in the SUSTAIN project
Particle contamination on Silimed breast implants poses minimal risk Particles were found on Silimed silicone-based breast implants that should not be there. These included man-made mineral fibres, such as glasswool and rockwool.
EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.
RIVM research basis for historic climate agreement on HFCs Scientific research by RIVM’s Guus Velders stood partly at the basis of the HFC global climate agreement.